Director of Business Development and International Affiliations, UC Davis Health System
Tod Stoltz graduated in 1993 with a degree in molecular biology from UC Davis, where he worked in the laboratory of Ray Rodriguez to develop a plant-based system for production of pharmaceutical proteins. In 1994 he helped move this technology out of UC Davis into a new company called Applied Phytologics Inc. (API), founded by Dr. Rodgriguez and headquartered in Sacramento. He worked there for nine years. He also helped start a small DNA-sequencing company called Davis Sequencing that provides DNA-sequencing services to academic and industrial researchers.
Stoltz left API to attend business school, and graduated in 2004 with a focus in technology management. While in business school, he worked as an intern at the UC Davis Health System (UCDHS), reporting to the CEO to start a unit called Technology Business Development, whose mission was to help commercialize new medical technology developed at UCDHS. At this job, he helped start several companies and licensed several important technologies to existing companies, including a new technology for proton radiotherapy that was developed in collaboration with Lawrence Livermore National Laboratory. He received an award from the Secretary of the Department of Energy for this work.
In 2007 Stoltz joined the Center for Biophotonics Science and Technology (CBST), an NSF‐funded research center, where his role was to expand and improve interactions between the center and industry. He also led several initiatives to form public-private partnerships that continue to support CBST research efforts.
In 2011 he became the director of business development and international affiliations for UCDHS, where his role is to expand relationships with companies in areas of strategic interest to UCDHS and to build relationships with foreign hospitals and universities in ways that further the mission of UCDHS.